Shahin Lockman, MD, MSc

Lockman, Shahin 2020 120x160Dr. Lockman is an infectious-disease trained clinician and has conducted clinical trials, epidemiologic and implementation science investigation related to HIV-1 in Botswana since 1996. One of her research focus areas is the safety and efficacy of antiretroviral drugs used for HIV treatment and prevention among pregnant and postpartum women; she currently serves as co-chair for the IMPAACT 2010 trial which is evaluating the safety and efficacy of DTG- vs. EFV-based antiretroviral treatment regimens in pregnant and postpartum women. Dr. Lockman also conducts research on health and neurodevelopmental outcomes in HIV-exposed/uninfected children and on community-based HIV prevention, and mentors more than 20 early stage investigators on a range of clinical research projects in Botswana. She is PI of the Botswana Clinical Trials Unit at the Botswana Harvard AIDS Institute Partnership (conducting ACTG, IMPAACT, and HPTN network trials).

Share and Enjoy